Back to results
US 2012/0258101 A1Published application
Combination therapies for b-cell lymphomas comprising administration of anti-cd20 antibody
OwnerAntonio J. Grillo-Lópezinventor
Life of this patent
Estimating the term…
Abstract
New combined therapeutic regimens for treatment of B-cell lymphomas are disclosed which comprise, in particular, administration of anti-CD20 antibodies to patients having low-, intermediate- or high-grade non-Hodgkin's lymphomas.
Claims4
A method for treating relapsed B cell lymphoma comprising administering to a patient having relapsed B cell lymphoma a therapeutically effective amount of an anti-CD20 antibody, wherein the patient has relapsed from stem-cell or bone marrow transplantation.
Dependencies are inferred from the claim text.